Position: Postdoc / Bioinformatician

Department: Clinical Cooperation Unit Molecular Hematology / Oncology - Translational Myeloma Research Group

Code number: 2023-0422

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

Our Clinical Cooperation Unit "Molecular Hematology/Oncology" is seeking a postdoc or bioinformatician to join the Research Group "Translational Myeloma".

The Research Group "Translational Myeloma" of the Heidelberg Myeloma Center focuses on molecular and pathophysiologic aspects of multiple myeloma, with special interest in mechanisms of drug resistance, spatial heterogeneity of clonal evolution, and novel therapeutic targets. Our group serves as the translational research core of the German-speaking Multiple Myeloma Study Group (GMMG) and is responsible for many correlative science projects in the context of multicenter clinical trials.


Job description:

  • Analysis and integration of large multi-omics datasets with clinical data (WGS, RNA-seq, proteomics, multi-parameter flow cytometry, single-cell sequencing)
  • Support and supervision of bioinformatic analysis performed by PhD and master students
  • Interpretation, presentation, project reports, publication of results
  • Collaboration and communication within a team of technicians, clinicians, scientists and pathologists as well as (inter)national project partners


  • Master's and PhD degree in life sciences
  • Ability to independently solve complex scientific / technical problems
  • Experience and skills in bioinformatics tools and in programming language (e.g. R, C, Python, Java, Matlab)
  • Team spirit, creativity, reliability, strong commitment, ability to think and work independently in a collaborative environment
  • Self-motivation and strong interpersonal skills with a track record of collaborative work in multidisciplinary research environments
  • Proficiency in written and spoken German and English

We offer:

  • Interesting, versatile workplace
  • Excellent framework conditions: state-of-the-art equipment and opportunity for international networking at the highest level
  • Remuneration according to TV-L incl. occupational pension plan for the public service and capital-forming payments
  • 30 days of vacation per year
  • Flexible working hours
  • Possibility of mobile work and part-time work
  • Family-friendly working environment, including parent-child room, counseling services, e.g. on Elder Care
  • Sustainable travel to work: subsidized Germany job ticket
  • Develop your full potential: access to the DKFZ International Postdoc Program and DKFZ Career Service with targeted offers for your personal development to further develop your talents
  • Our Corporate Health Management Program offers a holistic approach to your well-being

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.

Earliest possible start date: 01.03.2024

Duration: The position is initially limited to 2 years with the possibility of prolongation. ‚Äč

The position can in principle be part-time.

Application deadline: 13.12.2023


Prof. Dr. Marc-Steffen Raab
Phone +49 (0)6221 / 42-1450

Please note that we do not accept applications submitted via email.

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.

To apply for a position please use our online application portal (https://www.dkfz.de/en/stellenangebote/index.php).

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept applications submitted via email. We apologize for any inconvenience this may cause.